1. Pharmaceutical Manufacturing: The level of manufacturing excellence to be achieved by the Indian industry, including GMP compliance and adoption of futuristic manufacturing practices like cGMP and manufacturing outsourcing opportunities.
2. R&D: Thrust to help Indian companies increase investment in R&D to develop original molecules, especially with reference to the new Product Patent era.
3. Clinical Research: An emerging segment with huge potential, there is need to ensure international quality standards are followed, requirements of this segment which is in its nascent stages in India.
4. Manpower: A major challenge for the Indian industry, growing significantly over the years. There is need to develop manifold quality manpower anticipating the requirements by 2020.
5. Pharmacy Practices: The Indian pharmacy profession needs drastic upgradation of services to achieve global standards. More responsibilities for community pharmacists and hospital pharmacists.
6. Exports: Needs to develop a comprehensive strategy to identify potential opportunities in various continents.
7. Support for ISM: Tapping the potential of Indian Systems of Medicine like Ayurveda by supporting in standardization and global acceptance and to develop drugs based on plant origin.
8. Regulatory issues: Need to transform the proposed Central Drug Authority as a proactive partner instead of policing and develop a comprehensive pharmaceutical policy for future.
9. Pharmaceutical Journalism & documentation: At present the status of pharmaceutical journalism and pharmaceutical knowledge documentation in India is in its nascent stages and requires active interaction and support of the industry and academia to document the rich knowledge base.
10. IP rights: The Indian industry requires better understanding of IP rights and issues in the product patent era.